119 related articles for article (PubMed ID: 19514366)
21. Reducing ovarian cancer death rates through screening.
Hartge P
Cancer; 2011 Feb; 117(3):449-50. PubMed ID: 21254048
[No Abstract] [Full Text] [Related]
22. The role of ultrasound and tumour markers in the early detection of ovarian cancer.
Oram DH; Jeyarajah AR
Br J Obstet Gynaecol; 1994 Nov; 101(11):939-45. PubMed ID: 7999723
[No Abstract] [Full Text] [Related]
23. Can we now agree to use the same definition to measure response according to CA-125?
Rustin GJ
J Clin Oncol; 2004 Oct; 22(20):4035-6. PubMed ID: 15364965
[No Abstract] [Full Text] [Related]
24. Ovarian cancer: real progress in early detection.
Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
[No Abstract] [Full Text] [Related]
25. Ovarian cancer screening.
Eason EL
CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
[No Abstract] [Full Text] [Related]
26. [Tumor markers in cancer of the ovary].
Ritter J
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(8):1086-7. PubMed ID: 3450719
[No Abstract] [Full Text] [Related]
27. Application of proteomics in ovarian cancer: which sample should be used?
Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
[TBL] [Abstract][Full Text] [Related]
28. [Progress in the study of normal-sized ovary carcinoma syndrome].
Zeng DY; Shen J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1149-51. PubMed ID: 16029582
[No Abstract] [Full Text] [Related]
29. The importance of test positive predictive value in ovarian cancer screening.
Greene MH; Feng Z; Gail MH
Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
[No Abstract] [Full Text] [Related]
30. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
31. [Problems for tumor markers in gynecological malignancies].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):2-4. PubMed ID: 18366922
[No Abstract] [Full Text] [Related]
32. [Current situation and prospect of proteomics research in ovarian malignancies].
Cui H
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):577-8. PubMed ID: 17181963
[No Abstract] [Full Text] [Related]
33. GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.
Kolwijck E; Zusterzeel PL; Roelofs HM; Hendriks JC; Peters WH; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2176-81. PubMed ID: 19661073
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B
Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818
[TBL] [Abstract][Full Text] [Related]
35. The not-so-silent killer.
Mettner J
Minn Med; 2005 Feb; 88(2):12. PubMed ID: 17886789
[No Abstract] [Full Text] [Related]
36. Spontaneous uroperitoneum and elevated Ca-125.
Li YX; Vaux K; Coleman P
Eur J Intern Med; 2008 Nov; 19(7):e47-8. PubMed ID: 19013362
[No Abstract] [Full Text] [Related]
37. Was a recent manufacturer recall of CA-125 reagents necessary?
Hsu YM; McClellan A; Jackups R; Gronowski AM; Scott MG
Clin Chim Acta; 2011 Sep; 412(19-20):1886-7. PubMed ID: 21641338
[No Abstract] [Full Text] [Related]
38. Symposium on ovarian tumors. Foreword.
Barber HR
Clin Obstet Gynecol; 1969 Dec; 12(4):929-36. PubMed ID: 5382339
[No Abstract] [Full Text] [Related]
39. Comparison of surface plasmon resonance and capacitive immunosensors for cancer antigen 125 detection in human serum samples.
Suwansa-ard S; Kanatharana P; Asawatreratanakul P; Wongkittisuksa B; Limsakul C; Thavarungkul P
Biosens Bioelectron; 2009 Aug; 24(12):3436-41. PubMed ID: 19553100
[TBL] [Abstract][Full Text] [Related]
40. [An unusual ovarian tumor].
Goutallier-Ben Fadhel C; Nfoussi H; Znaidi N; Boufaroua A; Bouraoui S; Mzabi-Regaya S
Ann Pathol; 2009 Jun; 29(3):252-4. PubMed ID: 19619837
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
